[HTML][HTML] Addressing the challenges of pancreatic cancer: future directions for improving outcomes

M Hidalgo, S Cascinu, J Kleeff, R Labianca, JM Löhr… - Pancreatology, 2015 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC), which accounts for more than 90% of all
pancreatic tumours, is a devastating malignancy with an extremely poor prognosis, as …

Prognostication of survival in patients with advanced cancer: predicting the unpredictable?

D Hui - Cancer Control, 2015 - journals.sagepub.com
Background Prognosis is a key driver of clinical decision-making. However, available
prognostication tools have limited accuracy and variable levels of validation. Methods …

Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update

GA Masters, S Temin, CG Azzoli, G Giaccone… - Journal of Clinical …, 2015 - ascopubs.org
Purpose To provide evidence-based recommendations to update the American Society of
Clinical Oncology guideline on systemic therapy for stage IV non–small-cell lung cancer …

Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer

AC Enzinger, B Zhang, D Schrag… - Journal of clinical …, 2015 - ascopubs.org
Purpose To determine how prognostic conversations influence perceptions of life
expectancy (LE), distress, and the patient-physician relationship among patients with …

[HTML][HTML] Models of integration of oncology and palliative care

D Hui, E Bruera - Annals of palliative medicine, 2015 - apm.amegroups.org
Objective: Palliative care aims to improve cancer patients' quality of life through expert
symptom management, psychosocial and spiritual care, patient-clinician communication …

Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study

TW LeBlanc, JD O'Donnell… - Journal of oncology …, 2015 - ascopubs.org
Purpose: Patients with hematologic malignancies are less likely to receive specialist
palliative care services than patients with solid tumors. Reasons for this difference are poorly …

When and why should patients with hematologic malignancies see a palliative care specialist?

TW LeBlanc, A El-Jawahri - Hematology 2014, the American …, 2015 - ashpublications.org
Palliative care is a multidisciplinary approach to symptom management, psychosocial
support, and assistance in treatment decision-making for patients with serious illness and …

What keeps oncologists from addressing palliative care early on with incurable cancer patients? An active stance seems key

TA Pfeil, K Laryionava, S Reiter-Theil… - The …, 2015 - academic.oup.com
Background. Sympathetic and frank communication about the terminal nature of advanced
cancer is important to improve patients' prognostic understanding and, thereby, to allow for …

[HTML][HTML] Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?

C Davis - Social Science & Medicine, 2015 - Elsevier
There is evidence from some countries of a trend towards increasingly aggressive
pharmacological treatment of patients with advanced, incurable cancer. To what extent …

Prognostic understanding, quality of life and mood in patients undergoing hematopoietic stem cell transplantation

A El-Jawahri, L Traeger, K Kuzmuk, J Eusebio… - Bone marrow …, 2015 - nature.com
Little is known about how patients undergoing hematopoietic stem cell transplantation (HCT)
and their family caregivers (FC) perceive their prognosis. We examined prognostic …